^
BIOMARKER:

BRAF V600E

i
Other names: BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
BRAF V600E
Hairy Cell Leukemia
trametinib + dabrafenib
Sensitive
:
C3
Blood - 1 week - (New C3)
BRAF V600E
Colorectal Cancer
cetuximab + encorafenib + binimetinib
Sensitive
:
A1
ESMO 2022 - 3 weeks - (New C3)
BRAF V600E
Thyroid Gland Papillary Carcinoma
trametinib + dabrafenib
Sensitive
:
C1
ESMO 2022 - 3 weeks - (New C3)
BRAF V600E
Colorectal Cancer
cetuximab + encorafenib
Sensitive
:
A1
BRAF V600E
Melanoma
dabrafenib
Sensitive
:
A1
BRAF V600E
Non Small Cell Lung Cancer
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600E
Thyroid Gland Anaplastic Carcinoma
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600E
Thyroid Gland Anaplastic Carcinoma
dabrafenib
Sensitive
:
A1
BRAF V600E
Melanoma
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600E
Melanoma
vemurafenib + cobimetinib
Sensitive
:
A1
BRAF V600E
Melanoma
vemurafenib
Sensitive
:
A1
BRAF V600E
Melanoma
trametinib
Sensitive
:
A1
BRAF V600E
Solid Tumor
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600E
Melanoma
encorafenib + binimetinib
Sensitive
:
A1
BRAF V600E
Non Small Cell Lung Cancer
dabrafenib
Sensitive
:
A2
BRAF V600E
Non Small Cell Lung Cancer
vemurafenib
Sensitive
:
A2
BRAF V600E
Glioblastoma
trametinib + dabrafenib
Sensitive
:
A2
BRAF V600E
Ganglioglioma
trametinib + dabrafenib
Sensitive
:
A2
BRAF V600E
Ganglioglioma
vemurafenib + cobimetinib
Sensitive
:
A2
BRAF V600E
Ganglioglioma
vemurafenib
Sensitive
:
A2
BRAF V600E
Cutaneous Melanoma
trametinib + dabrafenib
Sensitive
:
A2
BRAF V600E
Biliary Tract Cancer
trametinib + dabrafenib
Sensitive
:
A2
BRAF V600E
Astrocytoma
trametinib + dabrafenib
Sensitive
:
A2
BRAF V600E
Astrocytoma
vemurafenib + cobimetinib
Sensitive
:
A2
BRAF V600E
Glioma
selumetinib
Sensitive
:
A2
BRAF V600E
Astrocytoma
cobimetinib
Sensitive
:
A2
BRAF V600E
Astrocytoma
vemurafenib
Sensitive
:
A2
BRAF V600E
Astrocytoma
trametinib
Sensitive
:
A2
BRAF V600E
Astrocytoma
dabrafenib
Sensitive
:
A2
BRAF V600E
Ganglioglioma
cobimetinib
Sensitive
:
A2
BRAF V600E
Ganglioglioma
trametinib
Sensitive
:
A2
BRAF V600E
Ganglioglioma
dabrafenib
Sensitive
:
A2
BRAF V600E
Cutaneous Melanoma
pembrolizumab
Sensitive
:
A2
BRAF V600E
Cutaneous Melanoma
nivolumab
Sensitive
:
A2
BRAF V600E
Colorectal Cancer
panitumumab + encorafenib
Sensitive
:
A2